SCYX - SCYNEXIS INC
IEX Last Trade
1.01
0.009 0.881%
Share volume: 1,879
Last Updated: Fri 27 Dec 2024 08:01:38 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.90%
PREVIOUS CLOSE
CHG
CHG%
$1.00
0.01
0.89%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-15 | 2022-11-09 | 2023-03-31 | 2023-05-10 | 2023-08-14 | 2023-11-13 | 2024-03-28 | 2024-05-08 | |
| Assets | |||||||||
| Total Assets | 135.612 M | 112.293 M | 87.810 M | 70.296 M | 154.856 M | 148.546 M | 128.412 M | 118.254 M | |
| Current Assets | 125.676 M | 103.565 M | 79.061 M | 59.767 M | 145.530 M | 128.641 M | 102.116 M | 101.673 M | |
| Inventories | 629.000 K | 786.000 K | 899.000 K | 1.105 M | 10.290 M | 13.114 M | 0.000 | 0.000 | |
| Other Current Assets | 4.145 M | 4.141 M | 2.503 M | 1.726 M | 21.918 M | 22.481 M | 24.911 M | 21.049 M | |
| Short Term Investments | 4.145 M | 4.141 M | 2.503 M | 1.726 M | 21.918 M | 22.481 M | 24.911 M | 21.049 M | |
| Total Receivables | 2.211 M | 2.493 M | 2.101 M | 2.060 M | 27.345 M | 4.594 M | 2.463 M | 0.000 | |
| Current Cash | 118.691 M | 96.090 M | 73.503 M | 54.821 M | 85.542 M | 88.072 M | 74.362 M | 80.244 M | |
| Total Non-current Assets | 9.936 M | 8.728 M | 8.749 M | 10.529 M | 9.326 M | 19.905 M | 26.296 M | 16.581 M | |
| Property Plant Equipment | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Assets | 8.852 M | 7.795 M | 8.178 M | 10.057 M | 2.621 M | 2.523 M | 2.539 M | 2.475 M | |
| Intangible Assets | 866.000 K | 770.000 K | 408.000 K | 309.000 K | 206.000 K | 103.000 K | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 135.612 M | 112.293 M | 87.810 M | 70.296 M | 154.856 M | 148.546 M | 128.412 M | 118.254 M | |
| Total liabilities | 90.132 M | 95.084 M | 84.577 M | 100.210 M | 61.778 M | 56.555 M | 55.450 M | 44.149 M | |
| Total current liabilities | 16.012 M | 14.264 M | 17.618 M | 45.644 M | 16.158 M | 16.790 M | 16.303 M | 27.349 M | |
| Accounts Payable | 9.960 M | 7.419 M | 5.937 M | 5.925 M | 3.416 M | 3.490 M | 7.149 M | 8.918 M | |
| Other liabilities | 37.110 M | 43.660 M | 29.645 M | 51.724 M | 42.860 M | 37.092 M | 36.566 M | 14.313 M | |
| Current long term debt | 199.000 K | 269.000 K | 282.000 K | 34.944 M | 310.000 K | 325.000 K | 340.000 K | 356.000 K | |
| Long term debt | 37.010 M | 37.160 M | 37.314 M | 2.842 M | 2.760 M | 2.673 M | 2.581 M | 2.487 M | |
| Other liabilities | 37.110 M | 43.660 M | 29.645 M | 51.724 M | 42.860 M | 37.092 M | 36.566 M | 14.313 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 45.480 M | 17.209 M | 3.233 M | -29.914 M | 93.078 M | 91.991 M | 72.962 M | 74.105 M | |
| Common stock | 43.285 M | 47.504 M | 47.614 M | 47.757 M | 47.837 M | 47.892 M | 47.925 M | 48.246 M | |
| Retained earnings | -378.275 M | -407.859 M | -422.288 M | -456.164 M | -333.904 M | -335.661 M | -355.247 M | -354.836 M |